Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Aging

dichlororibofuranosylbenzimidazole has been researched along with Aging in 1 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ryu, SW1
Woo, JH1
Kim, YH1
Lee, YS1
Park, JW1
Bae, YS1

Other Studies

1 other study available for dichlororibofuranosylbenzimidazole and Aging

ArticleYear
Downregulation of protein kinase CKII is associated with cellular senescence.
    FEBS letters, 2006, Feb-06, Volume: 580, Issue:3

    Topics: Aging; Animals; Casein Kinase II; Cell Line; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor

2006